Gupt Sandeep K, Yadav Ganesh, Gupta Anil K
Physical Medicine and Rehabilitation, King George's Medical University, Lucknow, IND.
Cureus. 2024 Jul 18;16(7):e64844. doi: 10.7759/cureus.64844. eCollection 2024 Jul.
Lumbar disc disease is one of the common causes of lower back pain caused by a change in the structure of the normal disc. Most of the time, disc disease happens as a result of aging and the normal breakdown that occurs within the disc. Caudal epidural steroid injections are the popular treatment for patients with chronic low back pain that does not respond to conservative management.
A retrospective survey was administered to 160 patients who had received caudal epidural injections for chronic low back pain in the past, but only 74 patients who completed the scheduled follow-ups were included in the study. They were divided into two groups based on the imaging modality used for guiding the caudal epidural steroid injections, either ultrasonography or fluoroscopy, and then assessed for improvement in pain on the Numeric Rating Scale (NRS), for functional improvement on the Oswestry Disability Index (ODI), and for satisfaction on the North American Spine Society Patient Satisfaction Scale (SSPSS).
Mean NRS pain scores improved significantly from baseline at 6.78 and 7.00 in the fluoroscopy and ultrasound groups, respectively, to 2.03 and 2.16 at 12 weeks post-procedure. The difference between the groups was not statistically significant (p > 0.05). The Oswestry Disability Index was completed at baseline and after 12 weeks of follow-up for both groups, and there was no significant difference between the two groups; the fluoroscopy group's mean Oswestry Disability Index scores were 52.4 at baseline and 35.6 at 12 weeks, whereas the scores for the ultrasound group were 50.3 at baseline and 37.9 at 12 weeks. Conversely, patient satisfaction as assessed using the SSPSS rose in both groups up to 12 weeks (p > 0.05).
The ultrasound- and fluoroscopy-guided caudal epidural steroid injections proved equally effective in easing the pain, disability, and satisfaction levels of patients with chronic lower back pain.
腰椎间盘疾病是因正常椎间盘结构改变导致下背痛的常见原因之一。大多数情况下,椎间盘疾病是衰老以及椎间盘内正常退变的结果。尾侧硬膜外类固醇注射是对保守治疗无反应的慢性下背痛患者的常用治疗方法。
对160例过去曾接受尾侧硬膜外注射治疗慢性下背痛的患者进行回顾性调查,但本研究仅纳入了74例完成预定随访的患者。根据用于引导尾侧硬膜外类固醇注射的成像方式,将他们分为两组,即超声引导组或荧光镜引导组,然后使用数字评分量表(NRS)评估疼痛改善情况,使用Oswestry功能障碍指数(ODI)评估功能改善情况,并使用北美脊柱协会患者满意度量表(SSPSS)评估满意度。
荧光镜引导组和超声引导组的平均NRS疼痛评分分别从基线时的6.78和7.00显著改善至术后12周时的2.03和2.16。两组之间的差异无统计学意义(p>0.05)。两组均在基线时和随访12周后完成了Oswestry功能障碍指数评估,两组之间无显著差异;荧光镜引导组的平均Oswestry功能障碍指数评分在基线时为52.4,在12周时为35.6,而超声引导组的评分在基线时为50.3,在12周时为37.9。相反,使用SSPSS评估的患者满意度在两组中均上升至12周(p>0.05)。
超声引导和荧光镜引导的尾侧硬膜外类固醇注射在缓解慢性下背痛患者的疼痛、功能障碍和满意度方面同样有效。